National Advisory Committee on Rural Health and Human Services; Notice of Meeting, 22940-22941 [E9-11441]

Download as PDF 22940 Federal Register / Vol. 74, No. 93 / Friday, May 15, 2009 / Notices 23236, 804–378–9130, (Formerly: Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.). Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713–856–8288/ 800–800–2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908–526–2400/800–437–4986, (Formerly: Roche Biomedical Laboratories, Inc.). Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709, 919–572–6900/800–833–3984, (Formerly: LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group). Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866–827–8042/ 800–233–6339, (Formerly: LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center). LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913–888–3927/800–873–8845, (Formerly: Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.). Maxxam Analytics,* 6740 Campobello Road, Mississauga, ON, Canada L5N 2L8, 905–817–5700, (Formerly: Maxxam Analytics Inc., NOVAMANN (Ontario), Inc.). MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651–636–7466/800–832–3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232, 503–413–5295/800–950–5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612–725– 2088. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661–322–4250/800–350–3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888–747–3774, (Formerly: University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory). Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800–328–6942, (Formerly: Centinela Hospital Airport Toxicology Laboratory). VerDate Nov<24>2008 16:43 May 14, 2009 Jkt 217001 Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509–755–8991/ 800–541–7891x7. Phamatech, Inc., 10151 Barnes Canyon Road, San Diego, CA 92121, 858–643– 5555. Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA 30340, 770–452–1590/800–729–6432, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline BioScience Laboratories). Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610–631–4600/877–642–2216, (Formerly: SmithKline Beecham Clinical Laboratories; SmithKline BioScience Laboratories). Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405, 866–370–6699/818–989–2521, (Formerly: SmithKline Beecham Clinical Laboratories). S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109, 505– 727–6300/800–999–5227. South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South Bend, IN 46601, 574–234–4176 x276. Southwest Laboratories, 4625 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040, 602–438–8507/800–279– 0027. St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma City, OK 73101, 405–272– 7052. STERLING Reference Laboratories, 2617 East L Street, Tacoma, Washington 98421, 800–442–0438. Toxicology & Drug Monitoring Laboratory, University of Missouri Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO 65203, 573–882–1273. Toxicology Testing Service, Inc., 5426 N.W. 79th Ave., Miami, FL 33166, 305–593–2260. US Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755– 5235, 301–677–7085. The following laboratory voluntarily withdrew from the NLCP on March 31, 2009: Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus, 1210 W. Saginaw, Lansing, MI 48915, 517–364–7400, (Formerly: St. Lawrence Hospital & Healthcare System). * The Standards Council of Canada (SCC) voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 Dated: May 8, 2009. Elaine Parry, Director, Office of Program Services, SAMHSA. [FR Doc. E9–11374 Filed 5–14–09; 8:45 am] BILLING CODE 4160–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration National Advisory Committee on Rural Health and Human Services; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given that the following committee will convene its sixty-second meeting. Name: National Advisory Committee on Rural Health and Human Services Dates and Times: June 9, 2009, 9 a.m.— 4:45 p.m. June 10, 2009, 8:45 a.m.—3 p.m. June 11, 2009, 8:45 a.m.—11 a.m. Place: Hampton Inn, 1720 Rapp Street, Rapid City, South Dakota 57701, Phone: 605–348–1911. Status: The meeting will be open to the public. Purpose: The National Advisory Committee on Rural Health and Human Services provides advice and recommendations to the Secretary with respect to the delivery, research, development and administration of health and human services in rural areas. Agenda: Tuesday morning, at 9 a.m., the meeting will be called to order by the Chairperson of the Committee, the Honorable David Beasley. The first presentation will be an overview of rural South Dakota by Dr. Sidney Goss, Professor of Demography, South Dakota School of Mines and Technology. The Committee will be formally welcomed by the South Dakota Office of Rural Health, Sandra Durick, Director. The Committee will hear presentations on the three chosen (DOT) regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSAaccredited laboratories was transferred to the U.S. HHS, with the HHS’ NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory (Federal Register, July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the Federal Register on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. E:\FR\FM\15MYN1.SGM 15MYN1 Federal Register / Vol. 74, No. 93 / Friday, May 15, 2009 / Notices Subcommittee topics. The first panel will focus on Primary Care Workforce. The confirmed speakers are Dr. Bruce Vogt, Chair of Family Medicine, University of South Dakota; Dr. Charles Hart, CEO of Regional Health System; and Josie Peterson, South Dakota PCO Director. The second panel is Home-Based Care Options for Seniors. The confirmed speakers are Deb Bowman, Committee Member and Secretary of the South Dakota Department of Social Services; and Senator Jean Hunhoff, head of home care services at Yankton, South Dakota, and member of the task force on Meeting the Continuum of Care Needs of the Elderly in South Dakota. The final panel of the day is Health Care Provider Integration. The confirmed speakers are Tom Dean, MedPAC Member; Scot Graff, Community Healthcare Association of the Dakotas; and Matt Michaels, Health Care Attorney. After the panel discussions, the Committee Chair will give an overview of the site visits. The Tuesday meeting will close at 4:45 p.m. Wednesday morning, at 8:45 a.m., the Committee will break into Subcommittees and depart to the site visits. The Primary Care Workforce Subcommittee will visit Phillip Health Services in Philip, South Dakota. The Home-Based Care Options for Seniors Subcommittee will visit Regional Health Hospice Center in Rapid City, South Dakota. The Health Care Provider Integration Subcommittee will visit Custer Regional Hospital in Custer, South Dakota. Transportation to the site visits will not be provided to the public. The Subcommittees will return to Rapid City, South Dakota at 3 p.m. The Wednesday meeting will close at 3 p.m. The final session will be convened on Thursday morning at 8:45 a.m. The meeting will open with a review of the Subcommittee site visits. The staff of the Office of Rural Health Policy will provide an update on the Department of Health and Human Services. The Committee will draft a letter to the Secretary or Designee and discuss the September meeting. For Further Information Contact: Anyone requiring information regarding the Committee should contact Jennifer Chang, MPH, Executive Secretary, National Advisory Committee on Rural Health and Human Services, Health Resources and Services Administration, Parklawn Building, Room 9A–55, 5600 Fishers Lane, Rockville, MD 20857, Telephone (301) 443–0835, Fax (301) 443–2803. Persons interested in attending any portion of the meeting should contact Michele Pray Gibson, Office of Rural Health Policy (ORHP), Telephone (301) 443–0835. The Committee meeting agenda will be posted on ORHP’s Web site https:// www.ruralhealth.hrsa.gov. Dated: April 11, 2009. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E9–11441 Filed 5–14–09; 8:45 am] BILLING CODE 4165–15–P VerDate Nov<24>2008 16:43 May 14, 2009 Jkt 217001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Pediatric Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Pediatric Advisory Committee. General Function of the Committee: To provide advice and recommendations to the agency on FDA’s regulatory issues. Date and Time: The meeting will be held on Tuesday, June 23, 2009, from 8:30 a.m. to 5 p.m. Location: Hilton Washington DC/ Rockville Executive Meeting Center, Plaza Ballroom, 1750 Rockville Pike, Rockville, MD 20852. ˜ Contact Person: Carlos Pena, Office of Science and Health Coordination, Office of the Commissioner (HF–33), Food and Drug Administration, 5600 Fishers Lane (for express delivery, rm. 14B–08), Rockville, MD 20857, 301–827–3340, or ˜ by e-mail: carlos.pena@fda.hhs.gov or FDA Advisory Committee Information Line, 1–800–741–8138 (301–443–0572 in the Washington, DC area), code 8732310001. Please call the Information Line for up-to-date information on this meeting. A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency’s Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. Agenda: On June 23, 2009, the Pediatric Advisory Committee will review and discuss reports by the agency, as mandated by the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, for ALVESCO (ciclesonide), ANDROGEL (testosterone), ASMANEX (mometasone furoate), COMBIGAN (brimonidine/ timolol), DEPAKOTE (divalproex sodium), DERMA–SMOOTHE F/S (fluocinolone acetate), DIOVAN (valsartan), HEPSERA (adefovir dipivoxil), INSPRA (eplerenone), MOXATAG (amoxicillin), OMNARIS PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 22941 (ciclesonide), and ZOMETA (zoledronic acid). FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA’s Web site after the meeting. Background material is available at https://www.fda.gov/ohrms/ dockets/ac/acmenu.htm, click on the year 2009 and scroll down to the appropriate advisory committee link. Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before June 9, 2009. Oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before June 1, 2009. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by June 2, 2009. Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to ˜ a disability, please contact Carlos Pena at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/oc/advisory/ default.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). E:\FR\FM\15MYN1.SGM 15MYN1

Agencies

[Federal Register Volume 74, Number 93 (Friday, May 15, 2009)]
[Notices]
[Pages 22940-22941]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11441]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


National Advisory Committee on Rural Health and Human Services; 
Notice of Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), notice is hereby given that the 
following committee will convene its sixty-second meeting.

    Name: National Advisory Committee on Rural Health and Human 
Services
    Dates and Times: June 9, 2009, 9 a.m.--4:45 p.m.
    June 10, 2009, 8:45 a.m.--3 p.m.
    June 11, 2009, 8:45 a.m.--11 a.m.
    Place: Hampton Inn,
    1720 Rapp Street,
    Rapid City, South Dakota 57701,
    Phone: 605-348-1911.
    Status: The meeting will be open to the public.
    Purpose: The National Advisory Committee on Rural Health and 
Human Services provides advice and recommendations to the Secretary 
with respect to the delivery, research, development and 
administration of health and human services in rural areas.
    Agenda: Tuesday morning, at 9 a.m., the meeting will be called 
to order by the Chairperson of the Committee, the Honorable David 
Beasley. The first presentation will be an overview of rural South 
Dakota by Dr. Sidney Goss, Professor of Demography, South Dakota 
School of Mines and Technology. The Committee will be formally 
welcomed by the South Dakota Office of Rural Health, Sandra Durick, 
Director. The Committee will hear presentations on the three chosen

[[Page 22941]]

Subcommittee topics. The first panel will focus on Primary Care 
Workforce. The confirmed speakers are Dr. Bruce Vogt, Chair of 
Family Medicine, University of South Dakota; Dr. Charles Hart, CEO 
of Regional Health System; and Josie Peterson, South Dakota PCO 
Director. The second panel is Home-Based Care Options for Seniors. 
The confirmed speakers are Deb Bowman, Committee Member and 
Secretary of the South Dakota Department of Social Services; and 
Senator Jean Hunhoff, head of home care services at Yankton, South 
Dakota, and member of the task force on Meeting the Continuum of 
Care Needs of the Elderly in South Dakota. The final panel of the 
day is Health Care Provider Integration. The confirmed speakers are 
Tom Dean, MedPAC Member; Scot Graff, Community Healthcare 
Association of the Dakotas; and Matt Michaels, Health Care Attorney. 
After the panel discussions, the Committee Chair will give an 
overview of the site visits. The Tuesday meeting will close at 4:45 
p.m.
    Wednesday morning, at 8:45 a.m., the Committee will break into 
Subcommittees and depart to the site visits. The Primary Care 
Workforce Subcommittee will visit Phillip Health Services in Philip, 
South Dakota. The Home-Based Care Options for Seniors Subcommittee 
will visit Regional Health Hospice Center in Rapid City, South 
Dakota. The Health Care Provider Integration Subcommittee will visit 
Custer Regional Hospital in Custer, South Dakota. Transportation to 
the site visits will not be provided to the public. The 
Subcommittees will return to Rapid City, South Dakota at 3 p.m. The 
Wednesday meeting will close at 3 p.m.
    The final session will be convened on Thursday morning at 8:45 
a.m. The meeting will open with a review of the Subcommittee site 
visits. The staff of the Office of Rural Health Policy will provide 
an update on the Department of Health and Human Services. The 
Committee will draft a letter to the Secretary or Designee and 
discuss the September meeting.
    For Further Information Contact: Anyone requiring information 
regarding the Committee should contact Jennifer Chang, MPH, 
Executive Secretary, National Advisory Committee on Rural Health and 
Human Services, Health Resources and Services Administration, 
Parklawn Building, Room 9A-55, 5600 Fishers Lane, Rockville, MD 
20857, Telephone (301) 443-0835, Fax (301) 443-2803.
    Persons interested in attending any portion of the meeting 
should contact Michele Pray Gibson, Office of Rural Health Policy 
(ORHP), Telephone (301) 443-0835. The Committee meeting agenda will 
be posted on ORHP's Web site https://www.ruralhealth.hrsa.gov.

    Dated: April 11, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-11441 Filed 5-14-09; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.